How Do Prices of Drugs for Weight Loss in the U.S. Compare to Peer Nations’ Prices? August 17, 2023 Issue Brief A class of drugs initially approved for diabetes treatment has captured the public’s and policymakers’ attention as interest in their off-label use for weight loss rises. The weight-loss benefits of these drugs have led to their prescribed use for obesity or overweight treatment. A new analysis compares list prices for…
Privately Insured People with Depression and Anxiety Face High Out-of-Pocket Costs June 23, 2023 Issue Brief This analysis finds that privately insured adults who were treated for depression and/or anxiety in 2021 spent almost twice as much on annual out-of-pocket costs compared to enrollees who were not treated for a mental health diagnosis.
